Ekso Bionics Holdings, Inc. Quarterly report [Sections 13 or 15(d)]

Quarterly report [Sections 13 or 15(d)]

Note 8 - Goodwill and Intangible Assets (Tables)

Note 8 - Goodwill and Intangible Assets (Tables)

3 Months Ended

Mar. 31, 2025

Notes Tables

Schedule of Finite-Lived Intangible Assets [Table Text Block]

		March 31, 2025
		Gross Carrying Amount				Accumulated Amortization				Impairment				Net Carrying Amount
Developed technology		$	2,310			$	(670	)		$	—			$	1,640
Trade name			2,310				N/A				N/A				2,310
Intellectual property			460				(12	)			(180	)			268
Customer relationships			140				(41	)			—				99
Total intangible assets		$	5,220			$	(723	)		$	(180	)		$	4,317

		December 31, 2024
		Gross Carrying Amount				Accumulated Amortization				Impairment				Net Carrying Amount
Developed technology		$	2,310			$	(598	)		$	—			$	1,712
Trade name			2,310				N/A				N/A				2,310
Intellectual property			460				(6	)			—				454
Customer relationships			140				(36	)			—				104
Total intangible assets		$	5,220			$	(640	)		$	—			$	4,580

Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]

Fiscal Year		*Amount*
2025 - remainder		$	247
2026			330
2027			330
2028			330
2029			330
2030 and thereafter			440
Total		$	2,007